Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart D Cook

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 6, 2011
A second case of Marburg's variant of multiple sclerosis with vasculitis and extensive demyelinationRania G A Elenein, Leroy R Sharer, Stuart D Cook, et al.
Ophthalmology|January 1, 2008
Outcomes of same-sizing versus oversizing donor trephines in keratoconic patients undergoing first penetrating keratoplastyPhilip D Jaycock, Mark N A Jones, John Males, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|June 14, 2005
Safety of serial monthly administration of triple-dose gadopentetate dimeglumine in multiple sclerosis patients: preliminary results of the BECOME trialLeo J Wolansky, Mohammad H Haghighi, Evangelia Sevdalis, et al.
Journal of Neurology|December 25, 2012
MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY studyGiancarlo Comi, Stuart D Cook, Gavin Giovannoni, et al.
Ophthalmology|October 10, 2009
Long-term topical steroid treatment after penetrating keratoplasty in patients with pseudophakic bullous keratopathyAdam H Ross, Mark N A Jones, Dan Q Nguyen, et al.
BMJ Open|December 4, 2012
Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b studyDouglas S Goodin, George C Ebers, Gary Cutter, et al.
Investigative Radiology|September 8, 2020
Gray Matter Nucleus Hyperintensity After Monthly Triple-Dose Gadopentetate Dimeglumine With Long-term Magnetic Resonance ImagingJohn J DeBevits, Reshma Munbodh, Devin Bageac, et al.
International Journal of MS Care|January 24, 2014
Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010Stuart D Cook, Suhayl Dhib-Jalbut, Peter Dowling, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 6, 2011
A second case of Marburg's variant of multiple sclerosis with vasculitis and extensive demyelinationRania G A Elenein, Leroy R Sharer, Stuart D Cook, et al.
Ophthalmology|January 1, 2008
Outcomes of same-sizing versus oversizing donor trephines in keratoconic patients undergoing first penetrating keratoplastyPhilip D Jaycock, Mark N A Jones, John Males, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|June 14, 2005
Safety of serial monthly administration of triple-dose gadopentetate dimeglumine in multiple sclerosis patients: preliminary results of the BECOME trialLeo J Wolansky, Mohammad H Haghighi, Evangelia Sevdalis, et al.
Journal of Neurology|December 25, 2012
MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY studyGiancarlo Comi, Stuart D Cook, Gavin Giovannoni, et al.
Ophthalmology|October 10, 2009
Long-term topical steroid treatment after penetrating keratoplasty in patients with pseudophakic bullous keratopathyAdam H Ross, Mark N A Jones, Dan Q Nguyen, et al.
BMJ Open|December 4, 2012
Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b studyDouglas S Goodin, George C Ebers, Gary Cutter, et al.
Investigative Radiology|September 8, 2020
Gray Matter Nucleus Hyperintensity After Monthly Triple-Dose Gadopentetate Dimeglumine With Long-term Magnetic Resonance ImagingJohn J DeBevits, Reshma Munbodh, Devin Bageac, et al.
International Journal of MS Care|January 24, 2014
Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010Stuart D Cook, Suhayl Dhib-Jalbut, Peter Dowling, et al.
Pageof 5